Refining first-line regimens for extensive-stage small-cell lung cancer

被引:0
作者
不详
机构
关键词
SURVIVAL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S136 / S138
页数:3
相关论文
共 15 条
[1]   Prognostic Value of Clinical Staging According to TNM in Patients With SCLC: A Real-World Surveillance Epidemiology and End-Results Database Analysis [J].
Arriola, Edurne ;
Trigo, Jose Manuel ;
Sanchez-Gastaldo, Amparo ;
Navarro, Alejandro ;
Perez, Coral ;
Crama, Leonardo ;
Ponce-Aix, Santiago .
JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (01)
[2]   Antiangiogenesis: Vessel Regression, Vessel Normalization, or Both? [J].
Augustin, Hellmut G. ;
Koh, Gou Young .
CANCER RESEARCH, 2022, 82 (01) :15-17
[3]   Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer [J].
Chan, Joseph M. ;
Quintanal-Villalonga, Alvaro ;
Gao, Vianne Ran ;
Xie, Yubin ;
Allaj, Viola ;
Chaudhary, Ojasvi ;
Masilionis, Ignas ;
Egger, Jacklynn ;
Chow, Andrew ;
Walle, Thomas ;
Mattar, Marissa ;
Yarlagadda, Dig V. K. ;
Wang, James L. ;
Uddin, Fathema ;
Offin, Michael ;
Ciampricotti, Metamia ;
Qeriqi, Besnik ;
Bahr, Amber ;
de Stanchina, Elisa ;
Bhanot, Umesh K. ;
Lai, W. Victoria ;
Bott, Matthew J. ;
Jones, David R. ;
Ruiz, Arvin ;
Baine, Marina K. ;
Li, Yanyun ;
Rekhtman, Natasha ;
Poirier, John T. ;
Nawy, Tal ;
Sen, Triparna ;
Mazutis, Linas ;
Hollmann, Travis J. ;
Pe'er, Dana ;
Rudin, Charles M. .
CANCER CELL, 2021, 39 (11) :1479-+
[4]  
Cheng Y, 2023, J THORAC ONCOL, V18, pS46, DOI 10.1016/j.jtho.2023.09.027
[5]  
Cheng Y, 2023, WCLC
[6]   Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities [J].
Gay, Carl M. ;
Stewart, C. Allison ;
Park, Elizabeth M. ;
Diao, Lixia ;
Groves, Sarah M. ;
Heeke, Simon ;
Nabet, Barzin Y. ;
Fujimoto, Junya ;
Solis, Luisa M. ;
Lu, Wei ;
Xi, Yuanxin ;
Cardnell, Robert J. ;
Wang, Qi ;
Fabbri, Giulia ;
Cargill, Kasey R. ;
Vokes, Natalie, I ;
Ramkumar, Kavya ;
Zhang, Bingnan ;
Della Corte, Carminia M. ;
Robson, Paul ;
Swisher, Stephen G. ;
Roth, Jack A. ;
Glisson, Bonnie S. ;
Shames, David S. ;
Wistuba, Ignacio I. ;
Wang, Jing ;
Quaranta, Vito ;
Minna, John ;
Heymach, John, V ;
Byers, Lauren Averett .
CANCER CELL, 2021, 39 (03) :346-+
[7]   A Bispecific DLL3/CD3 IgG-Like T-Cell Engaging Antibody Induces Antitumor Responses in Small Cell Lung Cancer [J].
Hipp, Susanne ;
Voynov, Vladimir ;
Drobits-Handl, Barbara ;
Giragossian, Craig ;
Trapani, Francesca ;
Nixon, Andrew E. ;
Scheer, Justin M. ;
Adam, Paul J. .
CLINICAL CANCER RESEARCH, 2020, 26 (19) :5258-5268
[8]   First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer [J].
Horn, L. ;
Mansfield, A. S. ;
Szczesna, A. ;
Havel, L. ;
Krzakowski, M. ;
Hochmair, M. J. ;
Huemer, F. ;
Losonczy, G. ;
Johnson, M. L. ;
Nishio, M. ;
Reck, M. ;
Mok, T. ;
Lam, S. ;
Shames, D. S. ;
Liu, J. ;
Ding, B. ;
Lopez-Chavez, A. ;
Kabbinavar, F. ;
Lin, W. ;
Sandler, A. ;
Liu, S. V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23) :2220-2229
[9]   Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy [J].
Li, Tian ;
Qiao, Tianyun .
SEMINARS IN CANCER BIOLOGY, 2022, 86 :117-125
[10]   Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133) [J].
Liu, Stephen, V ;
Reck, Martin ;
Mansfield, Aaron S. ;
Mok, Tony ;
Scherpereel, Arnaud ;
Reinmuth, Niels ;
Garassino, Marina Chiara ;
Carpeno, Javier De Castro ;
Califano, Raffaele ;
Nishio, Makoto ;
Orlandi, Francisco ;
Alatorre-Alexander, Jorge ;
Leal, Ticiana ;
Cheng, Ying ;
Lee, Jong-Seok ;
Lam, Sivuonthanh ;
McCleland, Mark ;
Deng, Yu ;
Phan, See ;
Horn, Leora .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) :619-+